90 related articles for article (PubMed ID: 7626202)
1. Regulation of human clotting factor IX cDNA expression in transgenic mice.
Hu Y; Qiu X; Xue J; Liu Z
Sci China B; 1995 Jul; 38(7):825-33. PubMed ID: 7626202
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of human coagulation factor IX cDNA expressed in cultured cells and in transgenic mice].
Hu Y; Qiu X; Xue J; Liu Z
Yi Chuan Xue Bao; 1995; 22(3):161-6. PubMed ID: 8851867
[TBL] [Abstract][Full Text] [Related]
3. Construction and high expression of retroviral vector with human clotting factor IX cDNA in vitro.
Lu D; Qiu X; Zheng B; Qiu X; Xue J
Sci China B; 1995 Jun; 38(6):705-12. PubMed ID: 7626200
[TBL] [Abstract][Full Text] [Related]
4. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors.
Dai YF; Qiu XF; Xue JL; Liu ZD
Sci China B; 1992 Feb; 35(2):183-93. PubMed ID: 1581003
[TBL] [Abstract][Full Text] [Related]
5. [The transfer and expression of human clotting factor IX in muscle mediated by electroporation].
Wang H; Wang F; Chen L; Xue J; Lu D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):476-8. PubMed ID: 11774220
[TBL] [Abstract][Full Text] [Related]
6. Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient.
Zhou JM; Dai YF; Qiu XF; Hou GY; Akira Y; Xue JL
Sci China B; 1993 Sep; 36(9):1082-92. PubMed ID: 8274202
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice can express mutant human coagulation factor IX with higher level of clotting activity.
Yan JB; Wang S; Huang WY; Xiao YP; Ren ZR; Huang SZ; Zeng YT
Biochem Genet; 2006 Oct; 44(7-8):349-60. PubMed ID: 17028784
[TBL] [Abstract][Full Text] [Related]
8. [High expression of human FIX(hFIX) in transgenic mice directed by goat beta-casein gene promoter].
Huang Z; Yan JB; Huang Y; Sun Q; Xiao YP; Huang Y; Zeng YT
Yi Chuan Xue Bao; 2002; 29(3):206-11. PubMed ID: 12182072
[TBL] [Abstract][Full Text] [Related]
9. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
10. Stage I clinical trial of gene therapy for hemophilia B.
Lu DR; Zhou JM; Zheng B; Qiu XF; Xue JL; Wang JM; Meng PL; Han FL; Ming BH; Wang XP
Sci China B; 1993 Nov; 36(11):1342-51. PubMed ID: 8142023
[TBL] [Abstract][Full Text] [Related]
11. Long-term expression of human factor IX cDNA in rabbits.
Zhou JM; Qiu XF; Lu DR; Lu JY; Xue JL
Sci China B; 1993 Nov; 36(11):1333-41. PubMed ID: 8142022
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of a hemophilia B transgenic mouse model on the basis of coagulation factor IX gene knock-out mouse].
Che WL; He Y; Yao ZZ; Li J; Fu JL
Yi Chuan Xue Bao; 2002 Jul; 29(7):594-8. PubMed ID: 12143307
[TBL] [Abstract][Full Text] [Related]
13. Factor IX gene therapy for hemophilia.
Fewell JG
Methods Mol Biol; 2008; 423():375-82. PubMed ID: 18370215
[TBL] [Abstract][Full Text] [Related]
14. Towards gene therapy for haemophilia B using primary human keratinocytes.
Gerrard AJ; Hudson DL; Brownlee GG; Watt FM
Nat Genet; 1993 Feb; 3(2):180-3. PubMed ID: 8499952
[TBL] [Abstract][Full Text] [Related]
15. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C
J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068
[TBL] [Abstract][Full Text] [Related]
17. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
18. Expression of active human blood clotting factor IX in transgenic mice: use of a cDNA with complete mRNA sequence.
Choo KH; Raphael K; McAdam W; Peterson MG
Nucleic Acids Res; 1987 Feb; 15(3):871-84. PubMed ID: 3029708
[TBL] [Abstract][Full Text] [Related]
19. Efficient delivery of human clotting factor IX after injection of lentiviral vectors in utero.
Chen XG; Zhu HZ; Gong JL; Li F; Xue JL
Acta Pharmacol Sin; 2004 Jun; 25(6):789-93. PubMed ID: 15169633
[TBL] [Abstract][Full Text] [Related]
20. [The study on the stable inheritance and expression of foreign gene in transgenic mice].
Yan JB; Xiao YP; Fang YD; Xi Y; Huang WY; Huang Y
Sheng Wu Gong Cheng Xue Bao; 2002 Nov; 18(6):758-60. PubMed ID: 12674651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
